at Nasdaq.com (Dec 15, 2014)
A 2-1 ruling by a federal appeals court overturns a ban on federal stem-cell funding. STEM...
A 2-1 ruling by a federal appeals court overturns a ban on federal stem-cell funding. STEM +8.1%, ASTM +2.6%, GERN +1%, CYTX +0.4%; PowerShares biotech and genome ETF (PBE) +0.3%.
From other sites
at MarketWatch.com (Feb 12, 2013)
at Fox Business (Aug 30, 2012)
at MarketWatch.com (Jul 5, 2011)
at MarketWatch.com (Jun 16, 2011)
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs